Access cutting-edge b-cell lymphoma treatment through this clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this St Louis location
Access b-cell lymphoma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related b-cell lymphoma treatment provided free
Check if you qualify for this b-cell lymphoma clinical trial in St Louis, MO
No-Cost Study Care
Local to St Louis
Convenient for MO residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This phase II trial compares epcoritamab to standard practice (observation) for the treatment of patients with B-cell lymphomas who are not in complete remission after treatment with CD19-directed chimeric antigen receptor T-cell (CAR-T) therapy. Epcoritamab is a bispecific antibody. It works by simultaneously attaching to a molecule called CD20 on cancerous B-cells and a molecule called CD3 on effector T-cells, which are a type of immune cell. When epcoritamab binds to CD20 and CD3, it brings t
Sponsor: Academic and Community Cancer Research United
Yes, this clinical trial (NCT06238648) has an active research site in St Louis, MO that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for b-cell lymphoma treatment options in St Louis, MO, this clinical trial (NCT06238648) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our St Louis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced b-cell lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all b-cell lymphoma clinical trials near you to find additional studies recruiting in your area.
See all lymphoma clinical trials recruiting in St Louis — not just this study.
Browse Lymphoma Trials in St Louis →